1. Home
  2. BCPC vs SRRK Comparison

BCPC vs SRRK Comparison

Compare BCPC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$180.10

Market Cap

5.8B

Sector

Industrials

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$44.63

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCPC
SRRK
Founded
1967
2012
Country
United States
United States
Employees
1355
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.9B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
BCPC
SRRK
Price
$180.10
$44.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$176.00
$51.20
AVG Volume (30 Days)
141.8K
757.3K
Earning Date
05-25-2026
04-10-2026
Dividend Yield
0.53%
N/A
EPS Growth
20.87
N/A
EPS
4.75
N/A
Revenue
$799,023,000.00
N/A
Revenue This Year
$7.99
N/A
Revenue Next Year
$2.77
$21,831.23
P/E Ratio
$37.81
N/A
Revenue Growth
13.56
N/A
52 Week Low
$139.17
$22.71
52 Week High
$183.01
$49.82

Technical Indicators

Market Signals
Indicator
BCPC
SRRK
Relative Strength Index (RSI) 63.71 44.17
Support Level $149.11 $42.74
Resistance Level $183.01 $48.79
Average True Range (ATR) 5.05 1.76
MACD -0.18 -0.25
Stochastic Oscillator 81.61 8.71

Price Performance

Historical Comparison
BCPC
SRRK

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: